Product information and disease descriptionPlace of product in therapy
Disease description
23 evidence topics · 17 sources
QTORIN rapamycin 3.9 percent gel
Microcystic lymphatic malformations
- Manufacturer
- Palvella Therapeutics
- Regulatory submission
- NDA submitted August 2026
- Last updated